Hepatitis delta virus infection

Area of Science:

• Hepatology and Virology
• Infectious Diseases

Background:

• Hepatitis delta virus (HDV) is a defective RNA virus that relies on hepatitis B virus (HBV) for its replication and infectivity.
• HDV and HBV co-infection is frequently observed in individuals with parenteral exposure, such as intravenous drug users and transfusion recipients.
• While co-infection is typically self-limiting in acute hepatitis cases, HDV superinfection in chronic HBV carriers (HBsAg carriers) can lead to severe outcomes, including chronic active liver disease.

Purpose of the Study:

• To elucidate the relationship between HDV and HBV infections.
• To describe the clinical course and outcomes of HDV and HBV co-infection and superinfection.
• To highlight preventive strategies against HDV infection.

Main Methods:

• Review of existing literature on HDV and HBV co-infection and superinfection.
• Analysis of clinical presentations and disease progression in affected patient populations.
• Evaluation of epidemiological data related to risk factors and transmission routes.

Main Results:

• HDV co-infection with HBV is most common in patients with significant parenteral exposure.
• Superinfection of HBsAg carriers with HDV can result in severe hepatitis and progression to chronic liver disease.
• The disease course is generally self-limiting in acute co-infection cases unrelated to chronic carriers.

Conclusions:

• HDV infection is entirely dependent on HBV.
• Active immunoprophylaxis against HBV is the sole effective preventive measure against HDV infection.
• Vaccination against HBV is crucial for preventing both HBV and HDV infections, particularly in high-risk populations.